Related Experiment Videos
Nature and management of infections in patients with advanced cancer
Texas Medicine
|May 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·1992
Lack of activity of amphotericin B in systemic murine fusarial infection.
The Journal of infectious diseases·1992
Viral pneumonia in the immunocompromised adult with neoplastic disease: the role of common community respiratory viruses.
Seminars in respiratory infections·1992
Evaluation of strategies for central venous catheter replacement.
Critical care medicine·1992
Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·1992
In vitro activity of Ro 23-9424, a dual-action antibacterial agent, against bacterial isolates from cancer patients compared with those of other agents.
Antimicrobial agents and chemotherapy·1992
Commentary: This Is Not a Drill.
Texas medicine·2021
Talk to Patients About: Vaccine Adverse Event Reporting System (VAERS).
Texas medicine·2021
Obstacles to Clear.
Texas medicine·2021
Expression of COL6A1 in Tumor Matrix of Cholangiocarcinoma and Its Mechanism of Tumor Progression.
Cancer reports (Hoboken, N.J.)·2026
Anesthetics and cancer biology: Translational evidence from perioperative modulation to drug repurposing (Review).
International journal of molecular medicine·2026
[CEACAM4 promotes glioblastoma progression by regulating a myeloid cell-mediated immunosuppressive tumor microenvironment].
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2026
Nuciferine Suppresses Inflammatory Hepatocarcinogenesis by Targeting cPLA2-Dependent Arachidonic Acid Metabolism.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026